U.S. Auto Stock News

Wondering whether Plug Power at US$3.79 still offers value after a wild ride, or if most of the opportunity is already priced in. The stock has returned 21.1% over the past week, 28.9% over the past month and 70.0% year to date, with a very large 441.9% return over the last year, but longer term 3 year and 5 year returns that are down 51.8% and 86.2% respectively. Recent headlines around hydrogen and fuel cell companies have kept investor attention on Plug Power, with coverage often focusing...

MacroGenics (MGNX) has opened Q1 2026 with revenue of about US$20.8 million and a basic EPS loss of roughly US$0.58, while trailing twelve month figures sit at revenue of about US$157.1 million and a basic EPS loss of around US$1.11. Over recent quarters, the company has reported revenue between US$13.2 million and US$72.8 million, with quarterly EPS ranging from a profit of about US$0.27 to losses such as US$0.65. This update keeps the focus on how the company is scaling revenue relative to...

Wondering whether Heritage Financial at around US$26.48 is offering genuine value or just looks reasonably priced on the surface? This article focuses on what the current share price might be implying about the company. The stock has slipped around 3.4% over the past week and 2.4% over the past month, yet it is still up 11.7% year to date and 13.4% over the past year, with a 3 year return of 85.0% and a 5 year return of 12.8%. Recent news coverage around regional banks has put more attention...

Why Forgent Power Solutions is in focus after Q3 earnings Forgent Power Solutions (FPS) drew attention after reporting Q3 2026 revenue of $378.7 million, representing 103% year over year growth, alongside record bookings, a $1.98 billion backlog, and higher full year revenue and adjusted EBITDA guidance. See our latest analysis for Forgent Power Solutions. Forgent Power Solutions’ Q3 update landed alongside a sharp shift in market sentiment, with the stock’s 1 day share price return of 10.26%...

Babcock & Wilcox Enterprises (BW) stock has been in focus after the company reported record first quarter 2026 results, highlighting strong AI driven project wins, a larger pipeline above $14b, and lower net debt. See our latest analysis for Babcock & Wilcox Enterprises. The latest Q1 update comes after a sharp re-rating in the stock, with a 1-day share price return of 9.66%, a 90-day share price return of 117.64%, and a year-to-date share price return of 234.17%. The 1-year total shareholder...

Flowers Foods was recently removed from the S&P MidCap 400 and added to the S&P SmallCap 600, a shift effective before trading opened on 18 May 2026 and tied to broader index reshuffling around related corporate transactions. State Street Corporation meanwhile disclosed a passive 5.7% beneficial stake in Flowers Foods held across its investment and trust affiliates, underscoring institutional interest without signaling any push for corporate change. Next, we’ll examine how Flowers Foods’...

Verrica Pharmaceuticals (VRCA) opened Q1 2026 with revenue of about US$5.0 million and a basic EPS loss of US$0.45, while trailing twelve month figures show revenue of US$37.2 million and a basic EPS loss of US$1.31. Over the past year, the company reported quarterly revenue moving from US$3.4 million in Q1 2025 to US$14.3 million in Q3 2025, then settling around the US$5.0 million mark in Q1 2026. EPS moved from a loss of US$1.03 to a small profit of US$0.02 in Q2 2025 before returning to...

Gilat Satellite Networks (NasdaqGS:GILT) opened 2026 with Q1 revenue of US$110.5 million and basic EPS of US$0.07. This set the tone for how its growth story is feeding through to the bottom line. The company reported revenue of US$92.0 million and an EPS loss of US$0.11 in Q1 2025, compared to revenue of US$110.5 million and an EPS profit of US$0.07 in Q1 2026. Trailing 12 month EPS is US$0.50 on revenue of US$470.1 million, which points to earnings growth supported by wider net margins. For...

a.k.a. Brands Holding (AKA) has opened 2026 with Q1 revenue of US$132.5 million and a reported loss of US$7.1 million, which translates to basic EPS of US$0.66 in the red. Over the past year, the company has seen trailing twelve month revenue sit at US$604.0 million with a loss of US$30.2 million, or basic EPS of US$2.81 in the red, setting a clear backdrop of continued unprofitability. For investors, the latest quarter keeps the spotlight firmly on margins and on whether the current profile...

Paysafe (PSFE) opened 2026 with Q1 revenue of US$442.7 million and a loss of US$36.5 million on a net income basis, which translated to basic EPS of a US$0.71 loss. Over the past five quarters, the company has seen revenue move from US$420.1 million in Q4 2024 to US$401 million in Q1 2025 and then to US$442.7 million in Q1 2026. Over the same period, basic EPS shifted from a profit of US$0.55 in Q4 2024 to losses of US$0.33 in Q1 2025 and US$0.71 in Q1 2026. For investors, the latest report...

International General Insurance Holdings Ltd. has reported past first-quarter 2026 results, with revenue of US$125.7 million and net income of US$21.7 million, both lower than the same period a year earlier. The drop in diluted earnings per share from continuing operations to US$0.49 from US$0.59 highlights pressure on profitability despite the company’s diversified insurance portfolio. We’ll now examine how this earnings softness, particularly the year-over-year net income decline, may...

Jack in the Box (JACK) opened Q2 2026 with total revenue of US$254.3 million and basic EPS of US$0.65, alongside net income excluding extra items of US$12.5 million, setting the tone for how its turnaround story is tracking. The company has seen quarterly revenue move between US$265.7 million and US$371.1 million over the past five reported periods, while basic EPS has ranged from US$0.30 to US$1.63. This gives investors a clear view of how earnings power has shifted through recent quarters...

Kornit Digital (NasdaqGS:KRNT) opened Q1 2026 with revenue of US$48.5 million and a basic EPS loss of US$0.19, alongside a quarterly net loss of US$8.2 million, setting a cautious tone for the latest update. Over recent periods the company has seen revenue move from US$60.7 million in Q4 2024 to US$58.9 million in Q4 2025 and then to US$48.5 million in Q1 2026. EPS has swung between a profit of US$0.05 and losses such as US$0.17 and US$0.19, which keeps the spotlight firmly on margin pressure...

In early May 2026, Vicor reported strong first-quarter results tied to AI and data‑center power demand, while multiple executives and directors exercised stock options and sold shares, alongside JPMorgan disclosing a 6.2% passive stake. The combination of robust AI‑related momentum and heavy insider selling, with no insider purchases over the past year, is sharpening investor focus on how management views Vicor’s current valuation and risk‑reward balance. Against this backdrop of strong AI...

Amentum Holdings (AMTM) has released its Q2 2026 results with revenue of US$3.5b and net income of US$54m, translating to basic EPS of US$0.22 for the quarter and trailing twelve month EPS of US$0.61. The company has seen quarterly revenue move between US$3.2b and US$3.9b over the past six reported periods, while quarterly basic EPS has ranged from US$0.02 to US$0.22. This sets up a picture of modest top line progress paired with gradually improving earnings power. For investors, the key...

Enanta Pharmaceuticals (ENTA) has just posted Q2 2026 results with revenue of US$17.2 million and a basic EPS loss of US$0.45, while trailing twelve month figures show revenue of US$69.2 million and a basic EPS loss of US$2.47. Over recent quarters the company has seen revenue move between US$14.9 million and US$18.6 million, with quarterly basic EPS losses ranging from roughly US$0.41 to US$1.06 and trailing twelve month net losses of US$62.0 million. For investors, the story this quarter is...

In the first quarter of 2026, COMPASS Pathways reported net income of US$91.2 million, or US$0.71 per share, and announced U.S. FDA acceptance of a rolling New Drug Application and a National Priority Review Voucher for its COMP360 psilocybin therapy in treatment-resistant depression. This combination of an accounting-driven swing to profitability and accelerated regulatory review for COMP360 marks a key moment for COMPASS Pathways’ shift from pure R&D focus toward potential commercial...

Stock performance and business profile International Business Machines (IBM) has delivered mixed share performance recently, with the stock up about 91% over the past 3 years but down 25% year to date and 16% over the past year. At a recent close of US$218.37 and a market value of about US$201.7b, IBM sits among the larger US technology and services companies. It combines software, consulting, infrastructure and financing under one umbrella. The company reports annual revenue of US$68.9b and...

VEON (NasdaqGS:VEON) has opened 2026 with Q1 numbers that put the focus squarely on earnings quality, reporting US$1.2 billion in revenue and basic EPS of US$1.42, while trailing twelve month EPS sits at US$7.65 on revenue of US$4.6 billion. Over recent quarters the company has seen revenue move from US$998 million in Q4 2024 to US$1.03 billion in Q1 2025, US$1.09 billion in Q2 2025 and US$1.20 billion in Q1 2026, with quarterly EPS ranging from a loss of US$2.00 in Q3 2025 to US$8.50 in Q2...

Why EnerSys is back in focus after its latest growth update EnerSys (ENS) has drawn fresh attention after outlining plans to expand in data centers and defense, including reallocating manufacturing capacity and steering its Greenville lithium facility toward drones and soldier power systems. See our latest analysis for EnerSys. The recent communications on AI infrastructure and defense electrification sit alongside very strong momentum, with a 30 day share price return of 20.45%, a year to...

QuickLogic (QUIK) opened Q1 2026 with revenue of about US$5.1 million and a basic EPS loss of US$0.13, setting the tone for another quarter where the top line and per share results remain firmly in focus for investors who track the stock through earnings season. Over the past year, the company has reported quarterly revenue in a range of roughly US$2.0 million to US$5.7 million, while basic EPS has ranged from a small profit of about US$0.01 per share to a quarterly loss of about US$0.24 per...

Perella Weinberg Partners recently reported first-quarter 2026 results showing net income of US$1.49 million, down sharply from US$17.34 million a year earlier, while also affirming a quarterly dividend of US$0.07 per Class A share payable in June. Alongside the weaker quarter, the firm expanded Chief Financial Officer Alexandra Gottschalk’s remit to include Chief Operating Officer, highlighting a tighter focus on operational execution as management cited longer timelines to complete complex...

Hasbro’s Q1 2026 earnings in focus Hasbro (HAS) opened 2026 with Q1 revenue of US$1,000.2 million and basic EPS of US$1.41, setting a clear snapshot of the business against a current share price of US$95.65. Over recent quarters the company has seen revenue move from US$887.1 million in Q1 2025 to US$1,000.2 million in Q1 2026, while basic EPS shifted from US$0.71 to US$1.41 over the same period. This gives investors a clearer look at how the top line and per share earnings are tracking. With...

Lineage Cell Therapeutics (LCTX) opened 2026 with Q1 revenue of US$1.7 million and a basic EPS loss of US$0.02, as net income excluding extraordinary items came in at a loss of US$4.8 million. The company has seen quarterly revenue move between US$1.5 million and US$6.6 million over the past year, while EPS has ranged from a loss of around US$0.13 per share to a small profit of US$0.00 per share, presenting a mixed picture regarding the path toward better margins. For investors, the latest...